Cite
HARVARD Citation
Reding, M. et al. (2021). Confirmed long‐term safety and efficacy of prophylactic treatment with BAY 94–9027 in severe haemophilia A: final results of the PROTECT VIII extension study. Haemophilia. 27 (3), pp. e347-e356. [Online].